Regenerative Medicine: A Global Strategic Business Report
San Jose, California (Vocus) October 18, 2010
Regenerative medicine is touted as the next-generation technology to revolutionize the medical system of the future. The industry is still in a nascent stage of development in terms of commercial applications, with majority products limited to the field of orthopedics. To date most of the commercial regenerative medicine products have been limited to the field of orthopedics. Majority of the products in other therapeutic areas are in pre-clinical or early clinical evaluation stage. Active support of governments around the world and technological breakthroughs are expected to result in high growth for the industry in the near future. Regenerative medicine also has the potential to emerge as one of the largest growth drivers of the global economy. The ageing population globally, plagued with various age-related cell dysfunctions provide a ready market for novel therapies based on tissue engineering and regenerative medicine. Unlike other industries, the regenerative medicine industry has reached the present stages mainly through private participation. Government funding and/or support for research into this promising field have only been a recent phenomenon. China has set up a US$1.0 billion fund for research into the field. Other major players such as Australia, India, Brazil, Argentina, South Korea, Singapore, and Malaysia have been witnessing active support from respective governments through funding or policies.
Advancements in biological science have drastically revolutionized the regenerative medicine domain. Exponential growth in the area is primarily due to the ageing baby boomer population and escalating incidence of osteoporosis, arthritis, and several other bone and joint traumas. Growing awareness for regenerative medicines and increasing usage of nonautograft products are also stimulating growth for these products. Additionally, the rising investments in R&D activity for sophisticated regenerative equipment and technologies, is further propelling overall growth. The field of regenerative medicine has already innovated products in the tissue engineered cartilage, bladder, and skin areas. Bioengineered organs that provide therapeutic protein are now the focus of future research. Another increasing focus area is telomeres and stem cells, which represent vital signs of ageing.
Regenerative medicine for bone and joint applications is a well-entrenched market in the US, exemplified by its dominant position, as stated by the new market research report on Regenerative Medicine The US represents the single largest market, trailed by Japan and Europe as the next most influential markets worldwide. In terms of growth, Europe is projected to march ahead of other world markets, propelled by renewed activity in Germany, UK and Belgium among others. An estimated more than 400 companies are related to tissue engineering or regenerative medicine within the EU, with Germany and the UK hosting the largest number of such firms.
Majority of players in the regenerative medicine market space are private firms and research institutions, interspaced with few government bodies and agencies. Key participants in the field include BioVest International, Inc, Curis, Inc., Cytori Therapeutics, Inc, DeveloGen AG, Forticell Bioscience, Inc, Geron Corporation, Integra Orthobiologics (US), LifeCell Corporation, Osiris Therapeutics, Inc., Tengion, Tepha Inc. and TiGenix N.V.
The report titled “Regenerative Medicine: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of industry overview, regulatory environment, product overview, technological innovations, recent industry activity, and profiles of market players worldwide. Analysis and overview is presented for major geographic markets such as US, Japan and Europe. Market analytics for Regenerative Medicine Products in value (US$) terms are analyzed for Bone and Joint Applications. The study also presents historic data for an insight into market evolution over the period 2003 through 2008.
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Regenerative_Medicine_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site http://www.StrategyR.com/